Given evidence showing prostate cancer responsiveness to insulin in mouse models [11] and insulin receptor expression by human prostate cancer cells [14], it is possible that hyperinsulinemia facilitates progression to castration-resistant prostate cancer (CRPC) [15]. The gene discussed is INS; the disease is hyperinsulinism.